Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Share Price Information for Beximco Pharma (BXP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 55.00
Ask: 60.00
Change: 2.50 (4.55%)
Spread: 5.00 (9.09%)
Open: 54.00
High: 57.50
Low: 54.00
Yest. Close: 55.00
BXP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
21st Sep 20207:00 amRNSBeximco Pharma receives eighth FDA approval
28th Aug 202011:06 amRNSSecond Price Monitoring Extn
28th Aug 202011:00 amRNSPrice Monitoring Extension
28th Aug 20208:31 amRNSBeximco and SII to cooperate on a COVID-19 vaccine
30th Jul 20207:00 amRNSBoard Change
23rd Jun 20207:00 amRNSQ3 Financial Results and Business Update
21st May 20207:00 amRNSWorld’s first generic remdesivir for COVID-19
4th May 20207:00 amRNSCOVID-19 Update
30th Mar 20207:00 amRNSBeximco donates PPE to healthcare professionals
24th Feb 20207:00 amRNSBeximco announces Commercial Agreement with Mylan
29th Jan 20207:00 amRNSHalf Year Results 2019-20
20th Jan 202011:06 amRNSPayment of Cash Dividend
23rd Dec 201910:46 amRNSAGM Statement
19th Nov 20198:57 amRNSAGM Notification
14th Nov 20197:00 amRNSResults for First Quarter Ended 30 September 2019
11th Nov 20197:00 amRNSResults for the 12 month period ended 30 June 2019
29th Oct 20197:00 amRNSNotification of Preliminary Results and AGM
8th Aug 20199:18 amRNSUpdate on Dividend and Tax legislation changes
30th Jul 20197:00 amRNSBeximco launches fifth product in the US market
18th Jul 20194:01 pmRNSDividend and Tax changes for Bangladesh companies
29th Apr 20197:00 amRNS3rd Quarter Results
24th Apr 20197:00 amRNSBeximco receives FDA approval for Cyproheptadine
20th Feb 20197:00 amRNSBeximco Pharma to Acquire Eight ANDAs from Sandoz
4th Feb 201911:32 amRNSAppointment of Broker
31st Jan 20197:00 amRNSHalf Year Results 2018-19
22nd Jan 20197:00 amRNSPayment of Cash Dividend
27th Dec 20187:00 amRNSEGM Statement
27th Dec 20187:00 amRNSAGM Statement
30th Nov 20187:00 amRNSAGM Notification
30th Nov 20187:00 amRNSEGM Notification
29th Nov 20188:30 amRNSBeximco Pharma wins at Scrip Awards 2018
14th Nov 20187:00 amRNSResults for First Quarter Ended 30 September 2018
7th Nov 20187:00 amRNSResults for the 12 month period ended 30 June 2018
26th Oct 20187:00 amRNSNotification of Preliminary Results and AGM
30th Jul 20187:00 amRNSUS FDA Approves Beximco Pharma's Nadolol Tablets
23rd Jul 20187:00 amRNSCommences export of fourth product to the US
27th Apr 20187:00 amRNS3rd Quarter Results
23rd Apr 20187:00 amRNSCommences Export of Third Product to the US Market
3rd Apr 20187:00 amRNSCompletion of the Acquisition of Nuvista Pharma
30th Jan 20187:00 amRNSHalf Year Results 2017-18
19th Jan 20187:00 amRNSPayment of Cash Dividend
19th Jan 20187:00 amRNSAcquisition of a Majority Stake in Nuvista Pharma
27th Dec 20177:00 amRNSAGM Statement
30th Nov 201710:30 amRNSBeximco Pharma wins at Scrip Awards 2017
23rd Nov 201711:53 amRNSNotice of AGM
14th Nov 20177:00 amRNSResults for First Quarter Ended 30 September 2017
7th Nov 20177:00 amRNSCommencement of Second Product Export to the US
6th Nov 201710:30 amRNSResults for the 12 month period ended 30 June 2017
26th Oct 20177:00 amRNSNotice of Preliminary Results and AGM
6th Oct 20177:00 amRNSSigns a Non-Binding MoU with Nuvista Pharma

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.